Australia markets open in 3 hours 53 minutes

Cardiff Oncology Inc (XE7C.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.05500.0000 (0.00%)
At close: 04:33PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
610
488
386
359
366
-
Cost of revenue
0
-
-
-
-
0
Gross profit
244.632
-
-
-
-
244.632
Operating expenses
Research development
31,813
32,857
27,107
17,376
11,235
-
Selling general and administrative
13,090
13,043
13,181
11,838
8,217
-
Total operating expenses
44,903
45,900
40,288
29,214
19,452
-
Operating income or loss
-44,293
-45,412
-39,902
-28,855
-19,086
-
Interest expense
-
-
-
0
2
0
Total other income/expenses net
9
-98
-383
300
-309
-
Income before tax
-40,229
-41,441
-38,704
-28,291
-19,307
-
Income from continuing operations
-40,229
-41,441
-38,704
-28,291
-19,307
-
Net income
-40,229
-41,441
-38,704
-28,291
-19,307
-
Net income available to common shareholders
-40,253
-41,465
-38,728
-28,315
-22,598
-
Basic EPS
-0.92
-0.93
-0.89
-0.73
-1.08
-
Diluted EPS
-0.92
-0.93
-0.89
-0.73
-1.08
-
Basic average shares
44,640
44,677
43,600
39,030
20,875
-
Diluted average shares
44,640
44,677
43,600
39,030
20,875
-